Celldex Therapeutics buy Wells Fargo & Company
Start price
22.07.26
/
50%
€30.47
Target price
22.07.27
€42.08
Performance (%)
12.27%
Price
20.08.26
€35.21
Summary
This prediction is currently active. The prediction currently has a performance of 12.27%. This prediction currently runs until 22.07.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | -8.164% |
| iShares Core DAX® | -1.586% |
| iShares Nasdaq 100 | -4.148% |
| iShares Nikkei 225® | -6.302% |
| iShares S&P 500 | -3.225% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target lowered by Wells Fargo & Company from $54.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€32.68
29.07.26
29.07.26
€63.18
29.07.27
29.07.27
7.71%
20.08.26
20.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€27.84
13.05.26
13.05.26
€46.01
13.05.27
13.05.27
22.88%
20.08.26
20.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
85.92%
02:15
02:15